Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Dec 13, 2019 (7 years ago)

Bimatoprost Ophthalmic Solution

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.

Affected NDC 68180-0429-03

Compare with the code on your package — it is the most precise check available.

Drug: Bimatoprost Category: Eye Drops & Ophthalmic

Recalling firm
Lupin Pharmaceuticals Inc.
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0635-2020 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Bimatoprost recalls

See all

Other recalls by Lupin Pharmaceuticals Inc.

All 2019 recalls